ACVRL1 and hereditary hemorrhagic telangiectasia: Mutations in the genes of endoglin or in the endothelial transmembrane receptor ALK1, a TGF-β type I receptor, cause the vascular disorder HHT (termed HHT-1 and HHT-2 accordingly) [3], [4].